High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 563-565

  Robert, Valérie ^c   Michel, Pierre ^a   Flaman, Jean Michel ^c   Chiron, Anne ^a   Martin, Cosette ^c   Charbonnier, Francoise ^c   Paillot, Bernard ^a   Frebourg, Thierry ^b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FRANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PLASMID; PRIORITY JOURNAL; SMOKING; SOMATIC MUTATION; TOBACCO; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; YEAST;

EID: 0034088872     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.563     Document Type: Article

References (25)

1. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
2. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
3. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
4. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAFI, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
5. 1 cyclin-dependent kinases. Cell, 75, 805-816.
6. 2 arrest after DNA damage. Science, 282, 1497-1501.
7. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p.53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
8. Jurgensmeier, J.M., Xie, Z., Deveraux, Q., Ellerby, L., Brendesen, D. and Reed, J.C. (1998) Bax directly induces release of cytochrome C from isolated mitochondria. Proc. Natl Acad. Sci. USA, 95, 4997-5002.
9. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogelstein, B.A. (1997) Model for p53-induced apoptosis. Nature, 389, 300-305.
10. Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., Harris, C.C. and Montesano, R. (1998) IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res., 26, 205-213.
11. Beroud, C., Verdier, F. and Soussi, T. (1998) p53 gene mutation: software and database. Nucleic Acids Res., 26, 200-204.
12. Ludwig, R.L., Bates, S. and Vousden, K.H. (1996) Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol., 16, 4952-4960.
13. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K.H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J., 15, 827-838.
14. Flaman, J.M., Robert, V., Lenglet, S., Moreau, V., Iggo, R. and Frebourg, T. (1998) Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene. 16, 1369-1372.
15. Hollstein, M.C., Metcalf, R.A., Welsh, J.A., Montesano, R. and Harris, C.C. (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl Acad. Sci. USA, 87, 9958-9961.
16. Audrezet, M.P., Robaszkiewicz, M., Mercier, J.P., Nousbaum, J.B., Bail, J.P., Hardy, E., Volant, A., Lozac'h, P., Charles, J.F., Gouerou, H. and Ferec, C. (1993) TP53 gene mutation profile in esophageal squamous cell carcinomas Cancer Res., 53, 5745-5749.
17. Sarbia, M., Porschen, R., Borchard, F., Horstmann, O., Willers, R. and Gabbert, H.E. (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer, 74, 2218-2223.
18. Ribeiro, U., Finkelstein, S.D., Safatle-Ribeiro, A.V., Landreneau, R.J., Clark, M.R., Bakker, A., Swalsky, P.A., Gooding, W.E. and Posner, M.C. (1998) p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer, 83, 7-18.
19. Montesano, R., Hollstein, M. and Hainaut, P. (1996) Genetic alterations in esophageal cancers and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69, 2225-2235.
20. Shi, S.T., Yang, G.Y., Wang, L.D., Xue, Z., Feng, B., Ding, W., Xing, E.P. and Yang, C.S. (1999) Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis, 20, 591-597.
21. Flaman, J.M., Frebourg, T., Moreau, V., Charbonnier, F., Martin, C., Chappuis, P., Sappino, A.P., Limacher, J.M., Bron, L., Benhattar, J., Tada, M., Van Meir, E.G., Estreicher, A. and Iggo, R.D. (1995) A simple p53 functional assay for screening cell lines, blood and tumors. Proc. Natl Acad. Sci. USA, 92, 3963-3967.
22. Frebourg, T., Flaman, J.M., Estreicher, A. and Iggo, R.D. (1998) Functional assay of the p53 tumor suppressor gene. In Cotton, R.G.H., Edkins, E. and Forrest, S.M. (eds) Mutation Detection: A Practical Approach. Oxford University Press, Oxford, pp. 211-222.
23. Denissenko, M.F., Pao, A., Tang, M. and Pfeifer, G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
24. Friedlander, P., Haupt, Y., Prives, C. and Oren, M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16, 4961-4971.
25. Thukral, S.K., Lu, Y., Blain, G.C., Harvey, T.S. and Jacobsen, V.L. (1995) Discrimination of DNA binding sites by mutant p53 proteins. Mol. Cell. Biol., 15, 5196-5202.